Werewolf Therapeutics, Inc. · NASDAQ:HOWL
Longwood Fund III GP, LLC's stake in Werewolf Therapeutics, Inc. fell to 3.50% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 11, 2026
Longwood Fund III GP, LLC's stake in Werewolf Therapeutics, Inc. fell to 3.50%, 1,677,082 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).
- Stake
- 3.50%
- Shares
- 1,677,082
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Longwood Fund III GP, LLC | 3.50% | 1,677,082 |
| Longwood Fund III, L.P. | 3.50% | 1,677,082 |
Source
Related
- Werewolf Therapeutics, Inc.
- Longwood Fund III GP, LLC
- Werewolf Therapeutics, Inc. shareholders
- Schedule 13G · Moll Peter · Sep 21, 2026
- Form 4 · Luke Evnin · Jul 8, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 2, 2026
- Form 4 · Luke Evnin · Jun 29, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 26, 2026